NLNK Shares Outstanding History



Below is a table of the NLNK shares outstanding history going back to 11/10/2011:

Date NLNK Shares Outstanding
11/10/201118.03M
12/13/201120.59M
3/19/201220.66M
4/15/201220.67M
5/4/201220.67M
8/10/201220.90M
10/24/201220.92M
3/12/201325.60M
5/6/201325.60M
8/5/201325.70M
11/5/201325.71M
3/7/201427.86M
5/6/201427.87M
7/31/201427.91M
11/6/201427.96M
3/10/201528.48M
5/7/201528.60M
7/29/201528.72M
8/20/201528.76M
11/3/201528.79M
2/23/201628.86M
4/26/201628.86M
5/18/201628.90M
8/2/201628.97M
10/26/201629.13M
11/2/201629.13M
2/28/201729.22M
5/3/201729.23M
8/1/201729.42M
10/31/201737.08M
3/2/201837.16M
5/7/201837.17M
8/1/201837.21M
10/30/201837.22M
2/27/201937.28M
5/6/201937.28M
8/6/201937.31M
12/31/201875.03M
10/31/201937.31M
2/25/202037.33M

Also see: NLNK Market Cap History
NLNK YTD Return
NLNK Historical Shares Outstanding:
+9.17% CAGR
NLNK Historical Shares Outstanding: +9.17% CAGR

Mouse over chart for data details
11/10/2011 ...2/25/2020
NewLink Genetics is a clinical-stage immuno-oncology company focused on discovering and developing immunotherapeutic products for the treatment of patients with cancer. Co.'s small-molecule product candidates in clinical development target the indoleamine-2, 3-dioxygenase (IDO) pathway. Co.'s product candidates include: indoximod and NLG802 (a prodrug of indoximod), which are IDO pathway inhibitors with mechanisms of action that center around breaking the immune system's tolerance to cancer; and NLG207, which is a nanoparticle-drug conjugate consisting of a cyclodextrin-based polymer backbone linked to camptothecin, a topoisomerase 1 inhibitor of the topoisomerase-1 inhibitor, camptothecin. We show 40 historical shares outstanding datapoints in our coverage of NLNK's shares outstanding history.

Understanding the changing numbers of NLNK shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like NLNK versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching NLNK by allowing them to research NLNK shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree NLNK Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
NewLink Genetics (NLNK) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

NLTX Shares Outstanding History
NMRA Shares Outstanding History
NMRD Shares Outstanding History
NMTC Shares Outstanding History
NMTR Shares Outstanding History
NOTV Shares Outstanding History
NOVN Shares Outstanding History
NPCE Shares Outstanding History
NRBO Shares Outstanding History
NRC Shares Outstanding History
More Healthcare companies »

 

NLNK Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.